Approvals (Drugs@FDA)

ICOSAPENT ETHYL

AUROBINDO PHARMA LTD · ICOSAPENT ETHYL

ANDA218949Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA218949
Sponsor name
AUROBINDO PHARMA LTD
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20260624
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    ICOSAPENT ETHYL
    Reference standard
    No
    Dosage form
    CAPSULE
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      ICOSAPENT ETHYL
      Strength
      1GM
Harmonized identifiers (openFDA)
Application number
ANDA218949
Brand name
ICOSAPENT ETHYL
Generic name
ICOSAPENT ETHYL
Manufacturer name
Aurobindo Pharma Limited
Product NDC
59651-812
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
ICOSAPENT ETHYL
RxCUI
1304979
SPL ID
b30afc7a-bffb-4c71-974f-1d977156eb46
SPL set ID
b30afc7a-bffb-4c71-974f-1d977156eb46
Package NDC
59651-812-08
UNII
6GC8A4PAYH
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.